TABLE 3.

Multivariable Models for Primary and Secondary Outcomes Using a Fine and Gray Competing Risk Model

	Primary Outcome			Secondary Outcome
	Parameter Estimate	p Value	HR (95% CI)	Parameter Estimate	p Value	HR (95% CI)
Age, per yr	0.02	0.08	1.02 (1.00–1.03)	0.01	0.12	1.01 (1.00–1.02)
History of
PCI	0.37	0.09	1.45 (0.95–2.22)	0.49	0.0004	1.63 (1.25–2.14)
MI	0.72	0.003	2.05 (1.28–3.28)	0.29	0.07	1.34 (0.98–1.82)
CHF	0.65	0.01	1.92 (1.17–3.15)	0.50	0.004	1.65 (1.17–2.32)
Diabetes	0.30	0.10	1.35 (0.94–1.94)	0.22	0.07	1.24 (0.99–1.57)
Hypertension	0.17	0.46	1.19 (0.75–1.89)	0.55	0.001	1.73 (1.24–2.42)
Tobacco use	0.48	0.006	1.62 (1.15–2.28)	0.31	0.006	1.37 (1.09–1.71)
LVESVI, ml/m2	0.01	0.09	1.01 (1.00–1.01)	0.01	0.02	1.01 (1.00–1.01)
LGE+	0.50	0.02	1.64 (1.08–2.51)	0.48	0.0005	1.62 (1.23–2.12)
Ischemia+	0.67	0.0004	1.96 (1.35–2.86)	0.73	<0.0001	2.08 (1.62–2.67)

Primary outcome was defined as cardiovascular death or nonfatal MI. Secondary outcome was defined by a composite of cardiovascular death, nonfatal MI, hospitalization for unstable angina or CHF, and late unplanned coronary arterial bypass surgery.

Abbreviations as in Tables 1 and 2.